Network

Cancer Commons Network

Cancer Commons is being developed one cancer at a time in partnership with leading professional and patient advocacy organizations, pharmaceutical companies, medical centers, and health informatics companies. These disease commons form a network that will exploit the significant economies of scale and opportunities for cross learning that come from rethinking cancer as a molecular, rather than organ-based disease.

Connect to Cancer Commons at info@cancercommons.org.

  • Who Should Join

    For physicians with patients who have failed the standard of care, Cancer Commons provides high value information and access to laboratory services to inform personalized cancer treatment planning.

    For patients with late-stage disease, Cancer Commons provides personalized and actionable information about relevant therapies, lab tests, and clinical trials that can be shared with your oncologists.

    For researchers who truly want to learn from and help patients, Cancer Commons provides unique opportunities to engage with a community of clinicians and patients committed to improving patient outcomes by continuously testing and refining their models of cancer biology and therapies.

    For life science companies involved in molecular diagnostics, therapeutics and laboratory services for oncology, Cancer Commons provides an ethical way to promote awareness and a revolutionary paradigm that will slash the time and cost of developing and distributing new products and services.